Today, healthcare providers are experiencing unprecedented levels of disruption. We are now in a radically changing world marked by rapidly evolving healthcare consumer expectations that are accelerating the industry several years forward. The industry has accepted that digital is here to stay, and this is evident across the board.
For instance, precision medicine is an emerging disease treatment and prevention approach that considers individual variability in genes, lifestyle, and environment. According to a recent report, the precision medicine market was valued at approximately US$58,450 million in 2020 and is expected to reach about US$98,550 million at a CAGR of 9.2 per cent by 2026. On page 06, Peter Raouf, Director, GCC Oncology Business, AstraZeneca, discusses precision medicine’s benefits and challenges.
On page 12, we speak to the RenAIssance team, who were selected by Ericsson and the UAE Ministry of Economy at a recent hackathon to help develop solutions that can tackle global problems using the latest technology. The team aims to transform kidney care with Artificial Intelligence and disrupt the current model of care, which is very expensive and requires a lot of specialist human and material resources.
Also, our annual American Hospitals Report (pg 30 to 40) highlights U.S. hospitals and health systems that have continued to scale up their telemedicine and remote second opinion (RSO) programmes for both domestic and international patients. We also profile leading U.S.-based institutions that are transforming healthcare delivery.